Patient Guide: Clinical Trial Comparing TQB2868 Injection Combined With Anlotinib Hydrochloride Capsules With Placebo Combined With Chemotherapy as First-line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 66 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT07165951
Status: NOT_YET_RECRUITING
Condition: Metastatic Pancreatic Ductal Adenocarcinoma
Phase: PHASE3

Where You Can Participate

This study is available at 66 locations across the country.

Top locations include:
  • • Hefei, Anhui
  • • Hefei, Anhui
  • • Beijing, Beijing Municipality
  • • And 63 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Clinical Trial Comparing TQB2868 Injection Combined With Anlotinib Hydrochloride Capsules With Placebo Combined With Chemotherapy as First-line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) - Join Clinical Trial NCTNCT07165951

How to Join This Clinical Trial - NCTNCT07165951

Learn how to participate in this PHASE3 trial studying an investigational therapy for Metastatic Pancreatic Ductal Adenocarcinoma. Current status: NOT_YET_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Metastatic Pancreatic Ductal Adenocarcinoma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Metastatic Pancreatic Ductal Adenocarcinoma
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
NOT_YET_RECRUITING
Study Identifier
NCTNCT07165951 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 66 locations. Find a study site near you:

Clinical Research Site

Hefei, Anhui 230001 - China

Status: Contact for availability

Clinical Research Site

Hefei, Anhui 230031 - China

Status: Contact for availability

Clinical Research Site

Beijing, Beijing Municipality 100034 - China

Status: Contact for availability

Clinical Research Site

Beijing, Beijing Municipality 100050 - China

Status: Contact for availability

Clinical Research Site

Beijing, Beijing Municipality 100071 - China

Status: Contact for availability

Clinical Research Site

Beijing, Beijing Municipality 102699 - China

Status: Contact for availability

Clinical Research Site

Chongqing, Chongqing Municipality 400010 - China

Status: Contact for availability

Clinical Research Site

Fuzhou, Fujian 350001 - China

Status: Contact for availability

Clinical Research Site

Xiamen, Fujian 361001 - China

Status: Contact for availability

Clinical Research Site

Xiamen, Fujian 361001 - China

Status: Contact for availability

And 56 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Metastatic Pancreatic Ductal Adenocarcinoma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships